[HTML][HTML] The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine …
MA Hassali, AA Alrasheedy, A McLachlan… - Saudi pharmaceutical …, 2014 - Elsevier
Generic medicines are clinically interchangeable with original brand medicines and have
the same quality, efficacy and safety profiles. They are, nevertheless, much cheaper in price …
the same quality, efficacy and safety profiles. They are, nevertheless, much cheaper in price …
Physician agency and adoption of generic pharmaceuticals
T Iizuka - American Economic Review, 2012 - aeaweb.org
I examine physician agency in health care services in the context of the choice between
brand-name and generic pharmaceuticals. I examine micro-panel data from Japan, where …
brand-name and generic pharmaceuticals. I examine micro-panel data from Japan, where …
Specialty drug prices and utilization after loss of US patent exclusivity, 2001–2007
RM Conti, ER Berndt - Measuring and modeling health care costs, 2016 - degruyter.com
The efforts of Conti were funded by a K07 CA138906 award from the National Cancer
Institute to the University of Chicago. Berndt's efforts were not sponsored. The funding …
Institute to the University of Chicago. Berndt's efforts were not sponsored. The funding …
Price regulation and relative delays in generic drug adoption
J Costa-Font, A McGuire, N Varol - Journal of health economics, 2014 - Elsevier
Increasing the adoption of generic drugs has the potential to improve static efficiency in a
health system without harming pharmaceutical innovation. However, very little is known …
health system without harming pharmaceutical innovation. However, very little is known …
Generic entry into the regulated Spanish pharmaceutical market
I Moreno-Torres, J Puig-Junoy, JR Borrell - Review of Industrial …, 2009 - Springer
This paper empirically analyses entry by generic firms into the strictly regulated Spanish
pharmaceutical market. We estimate a fixed effects negative binomial entry model using a …
pharmaceutical market. We estimate a fixed effects negative binomial entry model using a …
Relationship between corporate social responsibility and financial performance in the pharmaceutical industry
M Berete - 2011 - search.proquest.com
The findings regarding the relationship between corporate social responsibility (CSR) and
financial performance remain divided. Grounded on the stakeholder theory, this quantitative …
financial performance remain divided. Grounded on the stakeholder theory, this quantitative …
The generic drug market in Japan: will it finally take off?
Historically, brand-name pharmaceuticals have enjoyed long periods of market exclusivity in
Japan, given the limited use of generics after patent expiration. To improve the efficiency of …
Japan, given the limited use of generics after patent expiration. To improve the efficiency of …
[HTML][HTML] Does scale of public hospitals affect bargaining power? Evidence from Japan
K Noto, T Kojo, I Innami - International Journal of Health Policy and …, 2017 - ncbi.nlm.nih.gov
Background: Many of public hospitals in Japan have had a deficit for a long time. Japanese
local governments have been encouraging public hospitals to use group purchasing of …
local governments have been encouraging public hospitals to use group purchasing of …
REVIEW OF ASIA-PACIFIC'S HEALTHCARE SYSTEMS WITH EMPHASIS ON THE ROLE OF GENERIC PHARMACEUTICALS.
A Banerji, M Azad - Academy of Health Care Management …, 2013 - search.ebscohost.com
Asia-Pacific is the largest continent and the most populous. It also presents a study in
contrast because of wide income disparity inter and intra country within the continent …
contrast because of wide income disparity inter and intra country within the continent …
Optimal anti-cancer drug profiles for effective penetration of the anti-cancer drug market by generic drugs in Japan
S Shibata, M Matsushita, Y Saito… - … & Regulatory Science, 2018 - journals.sagepub.com
Background: The increased use of generic drugs is a good indicator of the need to reduce
the increasing costs of prescription drugs. Since there are more expensive drugs compared …
the increasing costs of prescription drugs. Since there are more expensive drugs compared …